| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.21 |
5e-06 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.15 |
0.0004 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0004 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.001 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.002 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |